227 related articles for article (PubMed ID: 14704790)
1. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide.
Göggel R; Winoto-Morbach S; Vielhaber G; Imai Y; Lindner K; Brade L; Brade H; Ehlers S; Slutsky AS; Schütze S; Gulbins E; Uhlig S
Nat Med; 2004 Feb; 10(2):155-60. PubMed ID: 14704790
[TBL] [Abstract][Full Text] [Related]
2. PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions.
Zimmerman GA; McIntyre TM
Trends Mol Med; 2004 Jun; 10(6):245-8. PubMed ID: 15177186
[No Abstract] [Full Text] [Related]
3. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase.
Yang Y; Yin J; Baumgartner W; Samapati R; Solymosi EA; Reppien E; Kuebler WM; Uhlig S
Eur Respir J; 2010 Aug; 36(2):417-27. PubMed ID: 19926744
[TBL] [Abstract][Full Text] [Related]
4. Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6.
Samapati R; Yang Y; Yin J; Stoerger C; Arenz C; Dietrich A; Gudermann T; Adam D; Wu S; Freichel M; Flockerzi V; Uhlig S; Kuebler WM
Am J Respir Crit Care Med; 2012 Jan; 185(2):160-70. PubMed ID: 22246702
[TBL] [Abstract][Full Text] [Related]
5. Role of sphingomyelinase in mitochondrial ceramide accumulation during reperfusion.
Ramírez-Camacho I; Bautista-Pérez R; Correa F; Buelna-Chontal M; Román-Anguiano NG; Medel-Franco M; Medina-Campos ON; Pedraza-Chaverri J; Cano-Martínez A; Zazueta C
Biochim Biophys Acta; 2016 Oct; 1862(10):1955-63. PubMed ID: 27479697
[TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of erythrocyte ceramide formation by platelet-activating factor.
Lang PA; Kempe DS; Tanneur V; Eisele K; Klarl BA; Myssina S; Jendrossek V; Ishii S; Shimizu T; Waidmann M; Hessler G; Huber SM; Lang F; Wieder T
J Cell Sci; 2005 Mar; 118(Pt 6):1233-43. PubMed ID: 15741229
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing ceramide: a major breakthrough or yet another marginal target for the treatment of acute lung injury?
Mercier JC; Dinh-Xuan AT
Pediatr Res; 2005 Mar; 57(3):319-21. PubMed ID: 15635045
[No Abstract] [Full Text] [Related]
9. Inhibition of ceramide biosynthesis ameliorates pathological consequences of spinal cord injury.
Cuzzocrea S; Deigner HP; Genovese T; Mazzon E; Esposito E; Crisafulli C; Di Paola R; Bramanti P; Matuschak G; Salvemini D
Shock; 2009 Jun; 31(6):634-44. PubMed ID: 18838947
[TBL] [Abstract][Full Text] [Related]
10. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation.
Falk S; Göggel R; Heydasch U; Brasch F; Müller KM; Wendel A; Uhlig S
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1734-42. PubMed ID: 10556149
[TBL] [Abstract][Full Text] [Related]
11. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis.
Peng H; Li C; Kadow S; Henry BD; Steinmann J; Becker KA; Riehle A; Beckmann N; Wilker B; Li PL; Pritts T; Edwards MJ; Zhang Y; Gulbins E; Grassmé H
J Mol Med (Berl); 2015 Jun; 93(6):675-89. PubMed ID: 25616357
[TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.
Predescu S; Knezevic I; Bardita C; Neamu RF; Brovcovych V; Predescu D
PLoS One; 2013; 8(9):e75846. PubMed ID: 24086643
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels.
Göggel R; Hoffman S; Nüsing R; Narumiya S; Uhlig S
Am J Respir Crit Care Med; 2002 Sep; 166(5):657-62. PubMed ID: 12204861
[TBL] [Abstract][Full Text] [Related]
14. Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets.
McVey MJ; Kim M; Tabuchi A; Srbely V; Japtok L; Arenz C; Rotstein O; Kleuser B; Semple JW; Kuebler WM
Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L625-L637. PubMed ID: 28283474
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide.
Becker KA; Fahsel B; Kemper H; Mayeres J; Li C; Wilker B; Keitsch S; Soddemann M; Sehl C; Kohnen M; Edwards MJ; Grassmé H; Caldwell CC; Seitz A; Fraunholz M; Gulbins E
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29084896
[No Abstract] [Full Text] [Related]
16. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.
Uhlig S; Göggel R; Engel S
Pharmacol Rep; 2005; 57 Suppl():206-21. PubMed ID: 16415501
[TBL] [Abstract][Full Text] [Related]
17. The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema.
Göggel R; Uhlig S
Eur Respir J; 2005 May; 25(5):849-57. PubMed ID: 15863642
[TBL] [Abstract][Full Text] [Related]
18. Inositol-trisphosphate reduces alveolar apoptosis and pulmonary edema in neonatal lung injury.
Preuss S; Stadelmann S; Omam FD; Scheiermann J; Winoto-Morbach S; von Bismarck P; Knerlich-Lukoschus F; Lex D; Adam-Klages S; Wesch D; Held-Feindt J; Uhlig S; Schütze S; Krause MF
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):158-69. PubMed ID: 22403805
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner.
Ito J; Nagayasu Y; Ueno S; Yokoyama S
J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
Chen CR; Voelkel NF; Chang SW
Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
